OrphAI Therapeutics

New Haven, CT · Founded 2013 · Privately Held (backing)

Developer of a precision therapeutics technology designed to treat cancer and rare diseases. OrphAI Therapeutics is based in New Haven, CT and was founded in 2013. Its last known valuation is $300 million. It has raised $155 million.

Last price · $/share
—
Implied valuation
$300.0M
Total raised
$154.5M
Last round
—
What is OrphAI Therapeutics worth?
$300.0Mlast known valuation
Free account
More of OrphAI Therapeutics with a free account
  • ·Watch OrphAI Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

OrphAI Therapeutics funding history

No rounds on record

No funding rounds for OrphAI Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

OrphAI Therapeutics valuation

OrphAI Therapeutics's last known valuation is $300 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How OrphAI Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For OrphAI Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about OrphAI Therapeutics

What is OrphAI Therapeutics worth?
OrphAI Therapeutics's last known valuation is $300.0M.
How much has OrphAI Therapeutics raised?
OrphAI Therapeutics has raised $154.5M in total funding across its recorded rounds.